John Shine

Corporate Officer/Principal presso The University of New South Wales

78 anni

Health Technology

Commercial Services

Consumer Services

Profilo

John Shine is currently a Professor of Molecular Biology & Medicine at The University of New South Wales.
Previously, he served as the Chairman of CSL Ltd.
from 2011 to 2018.
He also held positions as the Chairman of the National Health & Medical Research Council, Director of G2 Therapies Pty Ltd., Director of The Garvan Institute of Medical Research from 2011 to 2012, Director of Garvan Research Foundation, Member of the Prime Minister's Science, Engineering & Innovation Council, and President of the Museum of Applied Arts & Sciences.

Posizioni attive di John Shine

Società	Posizione	Inizio
The University of New South Wales	Corporate Officer/Principal	29/10/2010

Tutte le posizioni attive di John Shine

Precedenti posizioni note di John Shine

Società	Posizione	Fine
CSL LIMITED	Presidente	17/10/2018
The Garvan Institute of Medical Research The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia.	Direttore/Membro del Consiglio	01/01/2012
Museum of Applied Arts & Sciences	Presidente	-
Prime Minister's Science, Engineering & Innovation Council	Corporate Officer/Principal	-
National Health & Medical Research Council	Presidente	-

Vedi nel dettaglio l'esperienza di John Shine

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di John Shine

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CSL LIMITED	Health Technology

Aziende private	6
G2 Therapies Pty Ltd. G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia.	Health Technology
The Garvan Institute of Medical Research The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia.	Commercial Services
Garvan Research Foundation
National Health & Medical Research Council	Government
Prime Minister's Science, Engineering & Innovation Council
Museum of Applied Arts & Sciences

Vedi le connessioni aziendali